Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent primary liver
diseases worldwide and can develop into various conditions, ranging from simple steatosis …

Background: The incidence of glycolipid metabolic diseases is extremely high worldwide,
which greatly hinders people's life expectancy and patients' quality of life. Oxidative stress …

Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease in clinical practice. It
has been considered that NASH is one of the main causes of chronic liver disease, cirrhosis …

Ethnopharmacological relevance Nonalcoholic fatty liver disease (NAFLD) is a prevalent
liver disease, but currently has no specific medication in clinic. Antrodia cinnamomea (AC) is …

With the development of the social economy, unhealthy living habits and eating styles are
gradually affecting people's health in recent years. As a chronic liver disease, NAFLD is …

Inflammation is a key contributing factor in the pathogenesis of fatty liver diseases (FLD),
such as nonalcoholic fatty liver disease (NAFLD) and alcohol-associated liver diseases …

Non-alcoholic fatty liver disease (NAFLD) is a clinical pathological syndrome characterized
by the excessive accumulation of fat within liver cells, which can progress to end-stage liver …

Osteoporosis is a common bone disease in aging populations, particularly in
postmenopausal women. Anti‐resorptive and anabolic drugs have been applied to prevent …

Antrodia cinnamomea (AC), a potential medicinal fungus which possesses anti‐
inflammatory and anticancer activities, has been previously reported to be able to ameliorate …

Purpose Coronavirus disease 2019 (COVID-19) poses a global health challenge with
widespread transmission. Growing concerns about vaccine side effects, diminishing efficacy …